The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

NCT01973829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5215

Last updated 2018-08-20

No results posted yet for this study

Summary

The purpose of the study is to test whether the health care provider access and training in CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness), would facilitate timely and error free best-practice delivery and minimize preventable death and costly complications in critically ill patients.

Conditions

Interventions

OTHER

Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

This study is about training and implementation of best critical care practices in the international ICUs with variable resources facilitated by access to a specifically designed electronic checklist

Sponsors & Collaborators

Principal Investigators

  • Ognjen Gajic, MD · Mayo Clinic

  • Marija Kojicic, MD · Institute for Pulmonary Diseases, Novi Sad, Serbia

  • Rahul Kashyap, MD · Mayo Clinic

  • Marcus Schultz, MD · University of Amsterdam

  • Michelle N Gong, MD · Montefiore Medical Center, New York USA

  • Oguz Kilickaya, MD · Gulhane Military Medical Faculty, Ankara, Turkey

  • Neill Adhikari, MD · University of Toronto, Toronto Canada

  • Linda Bucher, PhD · College of Health Sciences, University of Delavere, Delawere USA

  • Daniel Talmor, MD · Beth Israel Deakoness Medical Center, Boston USA

  • Yue Dong, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • Belarus
  • Bosnia and Herzegovina
  • Brazil
  • China
  • Croatia
  • Dominican Republic
  • India
  • Ireland
  • Mexico
  • Mongolia
  • Pakistan
  • Philippines
  • Poland
  • Saudi Arabia
  • Serbia
  • Turkey (Türkiye)
  • Uganda

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01973829 on ClinicalTrials.gov